Ovarian Cancer Research Alliance (OCRA) has teamed up with BlackDoctor.org for a new video about genetic testing for ovarian cancer, highlighting its particular significance for Black women, who face disproportionately high mortality rates from the disease.
The video is the first in a new series from BlackDoctor.org and OCRA.
In this introductory video, Kevin M. Holcomb, MD, Chair of Obstetrics and Gynecology at Long Island Jewish Medical Center and North Shore University Hospital, explains how genetic testing can identify ovarian cancer risk, guide early intervention, and potentially improve outcomes. He also shares information about OCRA’s free genetic testing program which provides free kits for those who qualify.
Genetic testing is particularly important for Black women when it comes to ovarian cancer for a number of reasons,” said Dr. Holcomb. “Genetic testing gives you a chance of finding out that you may be at risk for ovarian cancer, and reducing your risk through either risk reducing surgeries or maybe medical treatments that help you to avoid developing ovarian cancer in the first place.
Read the full BlackDoctor.org article, “Genetic Testing and Ovarian Cancer: What Black Women Need to Know.”
More from BlackDoctor.org and OCRA:
- Watch the second installment in this series, “Genetic Testing and Ovarian Cancer Roundtable.”
- Watch an earlier six-part video series with OCRA, where members of OCRA’s community share their perspectives as Black women navigating ovarian cancer diagnosis, treatment, and care.
OCRA’s Free Genetic Testing Program is generously supported by AstraZeneca, GSK, Merck, and Genentech.
